ABVC BIOPHARMA, INC.

Regulatory Filings • Nov 16, 2020

NT 10-Q 1 ea129977-nt10q_americanbri.htm NOTIFICATION OF LATE FILING

Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(CHECK ONE):	☐ Form 20-F
For Period Ended:	September 30, 2020
☐ Transition Report on Form 10-K
☐ Transition Report on Form 20-F
☐ Transition Report on Form 11-K
☐ Transition Report on Form 10-Q
☐ Transition Report on Form N-SAR
For the Transaction Period Ended:

READ INSTRUCTION (ON BACK PAGE) BEFORE PREPARING FORM. PLEASE PRINT OR TYPE . NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

| American
BriVision (Holding) Corporation |
| --- |
| Full Name of Registrant |
| Former Name if Applicable |
| 44370
Old Warm Springs Blvd. |
| Address of Principal Executive Office (Street
and Number) |
| Fremont,
CA 94538 |
| City, State and Zip Code |

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

| ☒ | (a) | The reasons described in
reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| --- | --- | --- |
| ☒ | (b) | The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day following the prescribed due date; and |
| ☐ | (c) | The accountant’s statement or other exhibit
required by Rule 12b-25(c) has been attached if applicable. |

Field: Page; Sequence: 1

Field: /Page

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Registrant is unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2020 within the prescribed time period because it requires additional time for the review and completion of its financial statements.

SEC 1344 (05-06) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Field: Rule-Page

Field: /Rule-Page

PART IV - OTHER INFORMATION

| (1) | Name and telephone number of person
to contact in regard to this notification — Howard
Doong | 510 | 668-0881 |
| --- | --- | --- | --- |
| | (Name) | (Area Code) | (Telephone
Number) |
| (2) | Have all other periodic reports
required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940
during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?
If answer is no, identify report(s). | | |
| ☒
Yes | | | ☐ No |
| (3) | Is it anticipated that any significant
change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof? | | |
| ☐ Yes | | | ☒ No |
| | If so, attach an explanation of
the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made. | | |

| American
BriVision (Holding) Corporation | | | |
| --- | --- | --- | --- |
| (Name
of Registrant as Specified in Charter) | | | |
| has caused this notification to
be signed on its behalf by the undersigned hereunto duly authorized. | | | |
| Date | November
16, 2020 | By | /s/
Chihliang An |
| | | | Chihliang An, Chief Financial Officer, (Principal Financial and
Accounting Officer) |

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

Field: Page; Sequence: 2; Options: NewSection; Value: 2

Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence

Field: /Page

INTENTIONAL
MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)

3

Field: Rule-Page

Field: /Rule-Page